CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

®: CRE Regulatory Action of the Week

GAO Criticizes CMS
The Government Accounting Office criticized the Centers for Medicare & Medicaid Services in GAO testimony to Congress. The GAO focused on CMS' implementation of Medicare Part D, the program's new outpatient prescription drug benefit. The GAO found that CMS was disseminating confusing and inaccurate information about the new program to the program's beneficiaries and their advisors. Accurate CMS information is especially important because beneficiaries have until May 15, 2006, to enroll in the new prescription drug plan without risk of penalties.

  • Click to read GAO testimony and report